We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
274 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYRIZI risankizumab 180 mg/1.2 mL solution for injection pre-filled cartridge with on-body delivery system.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALPHAGAN P 1.0 brimonidine tartrate 1 mg/mL eye drop bottle.
-
Australian Public Assessment Report (AusPAR)Vyalev (foslevodopa and foscarbidopa) has been approved to treat idiopathic Parkinson’s disease with severe motor fluctuations despite optimised alternative pharmacological treatment.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Bag, medical device, reusable.
-
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Australian Public Assessment Report (AusPAR)Rinvoq (upadacitinib) has been approved for the treatment of adults with active non-radiographic axial spondyloarthritis.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial.